BRCA1 and BRCA2 Gene Mutations: I Know I Have Cancer, What Good is Testing?

A genetic counselor discusses how genetic testing can help guide treatment decisions as well as inform preventive measures.

11:06 AM

Author | Ian Demsky

graphic drawing of chromosome on black background
Graphic: Stephanie King

This article is the second piece of a three-part conversation on BRCA1 and BRCA2 gene mutations. Read "BRCA1 and BRCA2 Gene Mutations: The Basics" and "BRCA1 and BRCA2 Gene Mutations: I Have a Mutation, What Are My Options?"

BRCA1 and BRCA2 gene mutations are linked to the development of breast cancer, ovarian cancer and other types of cancer.

Genetic testing and counseling services can determine whether a person carries these mutations and, if they do, how the information could help inform cancer prevention or treatment decisions.

In the second of a three-part conversation, Kara Milliron, a genetic counselor at the University of Michigan Rogel Cancer Center's Breast and Ovarian Cancer Risk Evaluation Clinic, discusses different ways genetic testing can be useful.

MORE FROM THE LAB: Subscribe to our weekly newsletter

Milliron notes that genetic testing can provide useful information to people who have already been diagnosed with cancer as well as to those who are currently healthy.

"Genetic testing can be useful not only to inform the family about potential cancer risks, but it also can drive treatment decisions," she says. "And I think that this is a really important point because so many times when individuals are diagnosed with cancer, the first thing that they say to me is, 'Well, it's a moot point. I already have cancer, why would I undergo genetic testing?' The guidelines for offering BRCA1 and BRCA2 testing are for any individual who has a metastatic cancer that falls on the BRCA1 and BRCA2 spectrum."

That would include women and men diagnosed with metastatic breast cancer; women with pelvic cancers including cancer of the ovaries, fallopian tubes or peritoneum; and men and women with metastatic prostate or pancreatic cancer.

"And the reason behind that, is that BRCA1- and BRCA2-related cancers tend to respond to medications called PARP inhibitors," Milliron says. "So, the information we learn from genetic testing can potentially help identify drugs that their cancer is more likely to respond to."

Additionally, she says, if a patient's cancer hasn't spread and become metastatic, testing may still help doctors tailor a cancer screening plan for the patient.

"Also, if we test someone who has a cancer diagnosis and we find a mutation in a gene, we can then test other family members specifically for that gene mutation and we can say very conclusively yes or no, who is at risk," Milliron adds. "So, that's another reason to start with someone who has a cancer diagnosis — because if we find something, we can then do what we call cascade testing, which is test to see if other family members carry that specific gene mutation."

Identifying family members who don't carry a mutation is as important and finding those who do, she says.

"We can identify the people who are not at increased risk and we can save them from all of that additional screening, and so that is also a big public health win and helps reduce health care spending," Milliron says.


More Articles About: Cancer Care Cancer Counseling Cancer and Genetics Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine

MichMedmedia@med.umich.edu

734-764-2220

Newsletter

Get a weekly digest of medical research and innovation, straight to your inbox.

Subscribe
Featured News & Stories Genetic testing DNA chromosomes 3
Health Lab
BRCA1 and BRCA2 Gene Mutations: I Have a Mutation, What Are My Options?
A genetic counselor discusses decision-making for people who carry BRCA1 and BRCA2 mutations
genetic testing DNA chromosomes in blue
Health Lab
BRCA1 and BRCA2 Gene Mutations: The Basics
A genetic counselor discusses the impact of these mutations and the importance of collecting family histories.
Health Lab
When Is Genetic Testing for Breast Cancer Appropriate?
If you have a family history of breast cancer, you may also be at higher risk of developing the disease. This knowledge can boost surveillance and prevention efforts.
Health Lab
Support Without a Cancer Diagnosis: Helping People at Risk Find Comfort
Learn more about how people with a genetic predisposition to cancer can benefit from support groups as much as cancer patients, but options for the former group are limited.
cancer cells microscope blue green
Health Lab
Certain gene signaling rewires tumors after immunotherapy
For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?
older man holding hands up over head celebrating in hospital bed
Health Lab
Rebounding at 87 after CNS lymphoma
William Moldwin published a book, won awards and is making more plans for his future.